<- Go Home

Beximco Pharmaceuticals Limited

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Market Cap

BDT 38.8B

Volume

421.1K

Cash and Equivalents

BDT 1.7B

EBITDA

BDT 10.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

BDT 20.6B

Profit Margin

44.42%

52 Week High

BDT 127.00

52 Week Low

BDT 64.20

Dividend

4.60%

Price / Book Value

0.78

Price / Earnings

6.11

Price / Tangible Book Value

0.88

Enterprise Value

BDT 46.1B

Enterprise Value / EBITDA

4.35

Operating Income

BDT 8.8B

Return on Equity

12.45%

Return on Assets

7.62

Cash and Short Term Investments

BDT 2.9B

Debt

BDT 6.2B

Equity

BDT 53.6B

Revenue

BDT 46.3B

Unlevered FCF

BDT 2.8B

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches